Skip to content
MedsAcross

Manufacturer

Fourrts (India) Laboratories

Pharmaceutical manufacturer based in India
Indian manufacturerIndia
Products listed
11
Molecules
2
Therapy areas
2

Fourrts (India) Laboratories is a pharmaceutical manufacturer based in India. MedsAcross lists 11 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
India
Indian manufacturer
Yes
Also listed as
Fourrts (india) Laboratories Private Limited
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Fourrts (India) Laboratories products through licensed channels, with the documents your regulator needs.

Neurology

8 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Pregabalin 100 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 150 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 200 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 225 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 25 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 300 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 50 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 75 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request

Nephrology and urology

3 presentations

Nephrology and urology overview
MedicineActive ingredientRegisterAvailability
Tadalafil 10 mg tabletOralGeneric nameTadalafilUS FDAAvailable on request
Tadalafil 2.5 mg tabletOralGeneric nameTadalafilUS FDAAvailable on request
Tadalafil 5 mg tabletOralGeneric nameTadalafilUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Fourrts (India) Laboratories

Send a request for any of these products. We confirm the licensed source, documents and lead time.